New Clinical Research Study is Seeking Participants Diagnosed with Skin Lupus

In the past 50 years there have been very few clinical trials conducted for lupus and only one new drug has been approved.  Now, the number of clinical trials for people diagnosed with lupus is increasing¹.  One such clinical trial is now being conducted by researchers at multiple study centers across the United States.  This particular trial is for people who are diagnosed with skin lupus. 

This study is the first study for individuals with cutaneous lupus erythematosus (CLE) to evaluate the safety, tolerability, and efficacy of an investigational medication, CC-11050.  Participants involved in the study will be randomly selected to receive either 50 mg, 100mg, 200mg, or placebo (inactive substance) twice per day.   

Eligibility Criteria

Inclusion Criteria

To be included in the trial participants must:

1. Be 18 years or older

1. Have a clinical diagnosis of DLE (discoid lupus erythematosus )or SCLE (subcutaneous lupus erythematosus) for more than 16 weeks before screening for the study

1. Have active skin lesions

1. Be in good general health other than a lupus diagnosis

1. Be willing to use birth control

Exclusion Criteria (other exclusion criteria not listed here may apply)

1.  History of any significant major uncontrolled diseases

1. Pregnant or nursing

For more information or to see if you qualify for this study, see the Contact Us page or call 770-252-6900.